Blackcurrant Anthocyanins Research on Health Benefits of MCI, Alzheimer and Dementia
Alzheimer and Blackcurrant Anthocyanins
The number of Americans living with Alzheimer’s disease is growing rapidly, according to the Alzheimer’s Association. Some 5.7 million Americans currently have the disease. 5.5 million of them aged 65 and older. By 2025, the number of seniors with Alzheimer’s could reach 7.1 million, up nearly 29 percent. Every 65 seconds, someone in the United States develops Alzheimer’s disease. By 2050, that will occur every 33 seconds, the experts said.
A study found that in the last five years of life, the costs of a person with dementia, on average, total more than $300,000. This medical cost per person is the highest even compared to the cost of heart disease and cancer treatment.
Every 65 seconds, someone in the United States develops Alzheimer’s disease. By 2050, that will occur every 33 seconds, the experts said.
As new and natural remedy tool to fight against Alzheimer, numbers of researchers and scientific academies of the world are discovering that unique anthocyanins from blackcurrant extract (BCE) may have specific beneficial effects on Alzheimer through other physiologically effected points than cholesterol lowering and apolipoprotein isoform, which are believed to be the partial cause of Alzheimer disease.
Recently Niigata Pharmacological University has found that blackcurrant anthocyanins contained in the blackcurrant extract powder have potential ability of lowering β-amyloid (Aβ) production in brains inducing the onset of Alzheimer disease. Please click here for its research paper.
Niigata Pharmacology University
March 6, 2018